Early treatment of Becker muscular dystrophy patients with ACE inhibitors improves cardiac health

There is no consensus on when to introduce cardioprotective treatment in patients with Becker muscular dystrophy (BMD), and practice varies widely. A new study published in the Journal of Neuromuscular Diseases concludes that starting treatment with an ACE inhibitor as soon as cardiac function drops below the lower limit of the normal range reduces the risk of patients developing severe cardiomyopathy and heart failure, which are common outcomes in BMD.

source https://medicalxpress.com/news/2021-09-early-treatment-becker-muscular-dystrophy.html